ClinicalTrials.gg
CompletedNCT02427347Updated Aug 17, 2018

Acupuncture in the Regulation of Dai Meridian for the Metabolism of Visceral Adipose Tissue in Abdominal Obese Patients

An interventional study of Acupuncture and Healthy education in Abdominal Obesity and Metabolic Syndrome, sponsored by Dongfang Hospital Beijing University of Chinese Medicine. Completed at 1 site in China. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2018-08-17.

Sponsored by Dongfang Hospital Beijing University of Chinese Medicine · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Obesity, Abdominal with a site in China — 6 open to participants now, 7 under way, 1 of them phase 3. Obesity, Abdominal · China.

Enrollment
9th of 17
120 · median 120
Started
2014
the only one that year
No phase
12 of 19
5 open now
Registered
3rd of 19
by date
Lead sponsor
2 of 19
Dongfang Hospital Beijing University of Chinese Medicine

Among the 19 studies in Obesity, Abdominal with a site in China, this one is the 9th largest by enrollment of the 17 interventional ones that give a count, is the only one that started in 2014, is one of 12 with no phase, and was the 3rd registered.

Obesity, Abdominal

295 studies on the registry are indexed under Obesity, Abdominal; 45 are open to participants now.

Browse Obesity, Abdominal studies →

Open to participants now

6 of the 19 studies in Obesity, Abdominal with a site in China are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 26 Obesity, Abdominal studies recruiting now, 3 (12%) set no upper age limit and 21 (81%) stop at 75 or younger; 1 takes children under 18; 10 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Obesity, Abdominal with a site in China, or all of them as a file.
02

Study summary

To evaluate the effectiveness of acupuncture therapy combined with healthy education for patients with abdominal obesity.

Read the detailed description

This subject is a prospective, single-blind, parallel-group, randomized controlled clinical trial.120 patients with abdominal obesity are allocated into two groups with a ratio of 2:1.Randomized series was generated by computer. The allocation was concealed. Patients in the intervention group are received acupuncture therapy and healthy education. Patients in the control group are only given healthy education. The treatment in both intervention group and control group lasts for 8 weeks. Comparison of two groups of patients with abdominal fat thickness, fasting serum visfatin concentration, simple anthropometric parameters (including body weight, body mass index, waist circumference, hip circumference, waist-to-hip radio, waist-to-height radio, the percentage of body fat), fasting blood glucose, fasting insulin, glycosylated hemoglobin, fasting blood lipid (total cholesterol, triglyceride, high density lipoprotein, low density lipoprotein), uric acid, blood pressure, insulin resistance level, and obesity related lifestyle survey.

03

Conditions studied

  • Abdominal Obesity
  • Metabolic Syndrome
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Met the diagnostic criteria of abdominal obesity (waist circumference of male ≥ 90cm, waist circumference of female ≥ 80cm);
  • Ultrasound viscerofatty index ≥ 3;
  • Age between 18-70 years old;
  • Signed voluntarily.

Exclusion criteria

Exclusion Criteria:

  • Secondary obesity caused by endocrine, hereditary, nervous system,or drugs;
  • Within 3 months adjusted drug therapy for diabetes or hypertension or hyperlipidemia;
  • undergoing other therapies for reducing body mass and waist circumference, such as surgery, medication, etc;
  • participating or have participated in other studies;
  • pregnant or breast-feeding women;
  • critically ill, having hepatic-renal dysfunction or mental illness;
  • severe impairment in sight and hearing.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Intervention group

    Intervention including acupuncture treatment and healthy education.

    Other: Acupuncture · Other: Healthy education

  • Other
    Control group

    Healthy education is given as a baseline treatment.

    Other: Healthy education

Interventions

  • OtherAcupuncture

    Acupuncture needles of 0.3mm in diameter and 100mm in length are inserted into gallbladder-meridian(GB)26 about 25-65mm deep by an angle of 15°, following the path of Dai Meridian (towards medial and downside) . The other acupoints are inserted with needles of 0.25-0.3mm in diameter and 25-40mm in length approximately 10-30mm deep, with an angle of 90°. Electro-acupuncture is applied to both sides of GB26 and stomach-meridian(ST)25: cathode is connected to GB26; anode to ST25. Dense-disperse wave pattern and a wave frequency of 2/100 Hertz is chosen. The intensity of the electro-acupuncture is adjusted on average 4-8 milliampere. The needles are subsequently retained for 20min. The results of the study are based on 8 weeks, each week consisting of 3 sessions.

  • OtherHealthy education

    Healthy knowledge lectures and issuing brochures are given. Education of patients for conditioning and changing bad habits, diet, quit smoking, limit alcohol consumption, salt restriction, appropriate increase in physical activity.

06

What researchers measure

Primary outcomes

  1. Changes from Baseline in abdominal subcutaneous fat thickness at 8 weeks

    Including subcutaneous fat thickness 1 and 2

    Time frame: baseline and 8 weeks

  2. Changes from Baseline in abdominal visceral fat thickness at 8 weeks

    Including visceral fat thickness 1 and 2

    Time frame: baseline and 8 weeks

  3. Change from Baseline in antero-hepatic fat thickness at 8 weeks

    Antero-hepatic fat thickness (AHF) was determined by the distance of peritoneum to the hepatic cortex at the subcostal level.

    Time frame: baseline and 8 weeks

  4. Change from Baseline in perirenal fat thickness at 8 weeks

    Perirenal fat thickness (PRF) was determined by the thickest one of the perirenal fat capsule of the right kidney short axis, when the right renal short axis and the maximum width of the renal sinus were clearly displayed.

    Time frame: baseline and 8 weeks

  5. Change from Baseline in ultrasound viscerofatty index at 8 weeks

    ultrasound viscerofatty index (UVI) = (visceral fat thickness 1 + visceral fat thickness2)/(subcutaneous fat thickness 1 + subcutaneous fat thickness 2)

    Time frame: baseline and 8 weeks

  6. Change from Baseline in fasting serum visfatin at 8 weeks

    5ml venous blood was told after an 8 hours fast. Visfatin was measured by enzyme-linkedimmuno sorbent assay (ELISA).

    Time frame: baseline and 8 weeks

Secondary outcomes

  1. Change from Baseline in body weight

    It's made at the situation of fasting, after emptying bowels, with minimal clothing, without headdress and footwear, at the end of expiration.

    Time frame: baseline, 4 weeks and 8 weeks

  2. Change from Baseline in body mass index

    Body mass index (BMI) = body weight(kg)/height(m)/height(m)

    Time frame: baseline, 4 weeks and 8 weeks

  3. Change from Baseline in waist circumference

    WC was measured at the level between the inferior portion of 12th rib and iliac crest.

    Time frame: baseline, 4 weeks and 8 weeks

  4. Change from Baseline in hip circumference

    HC was measured at the level of the most prominent point of the pelvis.

    Time frame: baseline, 4 weeks and 8 weeks

  5. Change from Baseline in waist-to-hip radio

    waist-to-hip radio (WHR) = waist circumference(cm)/hip circumference(cm)

    Time frame: baseline, 4 weeks and 8 weeks

  6. Change from Baseline in waist-to-height radio

    waist-to-height radio (WHtR) = waist circumference(cm)/height(cm)

    Time frame: baseline, 4 weeks and 8 weeks

  7. Change from Baseline in the percentage of body fat

    the percentage of body fat = 1.2×BMI+0.23×age-5.4-10.8×gender(M=1,F=0)

    Time frame: baseline, 4 weeks and 8 weeks

  8. Change from Baseline in fasting blood glucose at 8 weeks

    5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.

    Time frame: baseline and 8 weeks

  9. Change from Baseline in fasting insulin at 8 weeks

    5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.

    Time frame: baseline and 8 weeks

  10. Change from Baseline in glycosylated hemoglobin at 8 weeks

    5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.

    Time frame: baseline and 8 weeks

  11. Change from Baseline in fasting total cholesterol at 8 weeks

    5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.

    Time frame: baseline and 8 weeks

  12. Change from Baseline in fasting triglyceride at 8 weeks

    5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.

    Time frame: baseline and 8 weeks

  13. Change from Baseline in fasting high density lipoprotein cholesterol at 8 weeks

    5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.

    Time frame: baseline and 8 weeks

  14. Change from Baseline in fasting low density lipoprotein cholesterol at 8 weeks

    5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.

    Time frame: baseline and 8 weeks

  15. Change from Baseline in fasting uric acid at 8 weeks

    5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.

    Time frame: baseline and 8 weeks

  16. Change from Baseline in blood pressure at 8 weeks

    Time frame: baseline and 8 weeks

  17. Change from Baseline in insulin resistance level at 8 weeks

    Time frame: baseline and 8 weeks

  18. Change from Baseline in obesity related lifestyle survey at 8 weeks

    Time frame: baseline and 8 weeks

07

Study locations

1 site
  • Department of Acupuncture and Moxibustion, Dongfang Hospital, Beijing University of Chinese Medicine
    Beijing, Beijing 100078, China
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2014, a primary completion of Apr 2015 and a completion of Sep 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2015
First posted
Apr 28, 2015
Start
Jun 2014
Primary completionActual
Apr 2015
CompletionActual
Sep 2017
Last update
Aug 17, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02427347
Lead sponsor
Dongfang Hospital Beijing University of Chinese Medicine
Collaborators
Beijing Municipal Science & Technology Commission, Beijing University of Chinese Medicine
Responsible party
Hui Hu (Principal Investigator, Dongfang Hospital Beijing University of Chinese Medicine) — Principal investigator
First posted
Apr 28, 2015
Start date
Jun 2014
Primary completion
Apr 2015
Completion
Sep 2017
Last update
Aug 17, 2018

Study contacts

Hui Hu, doctor
study chair · Department of Acupuncture and Moxibustion, Dongfang Hospital, Beijing University of Chinese Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion